C-FBJIMuna Therapeutics
small molecules, microglia, resilience
modulatingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-FBJI
C-FBJIC-FBJIsmall molecules, microglia, resilience
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Muna Therapeutics states that it is developing transformative therapeutics aimed at preserving brain function and enhancing resilience against neurodegenerative disease. The company presents its core belief as the possibility of discovering and developing therapies that can slow or stop major neurodegenerative conditions such as Alzheimer’s disease, Frontotemporal Dementia, and Parkinson’s disease.
SourceMuna Therapeutics states that it is focused on discovering and developing transformative therapies to preserve brain function and enhance resilience against neurodegenerative diseases. The company presents the belief that these diseases, including Alzheimer's, Frontotemporal Dementia, and Parkinson's, can be slowed or stopped through targeted therapeutic development.
SourceMuna Therapeutics states that it is focused on discovering and developing transformative therapies to preserve brain function, enhance resilience, and slow or stop devastating neurodegenerative diseases, specifically including Alzheimer’s, Frontotemporal Dementia, and Parkinson’s.
Source